Provider
QP44-21 MHCP Pharmacy Benefit Update – New Drug-Related Prior Authorization (PA) with Quantity Limit (QL) Criteria: Zeposia® (ozanimod)
Program effective Date: May 26, 2021
Documents & Forms Results
Displaying 1301 - 1310 of 3680 results
Provider
2021 June Provider Press
Program effective Date: May 25, 2021
Provider
BlueRide Incident Report Form
Provider
QP41-21 Commercial and MHCP Pharmacy Benefit Exclusion for Qutenza®
Program effective Date: May 12, 2021
Provider
QP40-21 Commercial Pharmacy Benefit Update – New and Revised Drug-Related Prior Authorization (PA) Requirement Notification – Effective July 1, 2021
Program effective Date: May 12, 2021
Provider
QP42-21 MHCP Pharmacy Benefit Update – New Drug-Related Prior Authorization (PA) with Quantity Limit (QL) Criteria: Hemophilia Agents
Program effective Date: May 12, 2021
Provider
QP2-21 Update for New to Market Medical Drugs: Aducanumab, Casimersen, Evinacumab, Idecabtagene Vicleucel, and Pegunigalsidase Alfa
Program effective Date: Jan 13, 2021